Successful treatment of generalized pustular psoriasis with biological agents: a case report and bibliographic review
DOI:
https://doi.org/10.59420/remus.10.2023.177Keywords:
Generalized pustular psoriasis, Systemic manifestations, Clinical diagnosis, Biological therapyAbstract
Generalized pustular psoriasis (GPP) is a multisystem, acute and severe variant of psoriasis with a clinical presentation of erythematous and edematous plaques on which multiple pustules appear. Systemic manifestations are frequent and often severe. Complications that can develop include sepsis and kidney, liver, respiratory, and heart failure. 50% of patients require hospitalization. Reported mortality rates are 2 to 16%.
We present the case of a 21-year-old female patient with history of plaque psoriasis, located in the lower extremities, with 3 years of evolution and with poor adherence to treatment based on topical steroids. The patient began suffering from the condition 48 hours prior to her admission to the emergency department with pustular, painful, erythematous-based lesions that covered 100% of the total body surface, in addition to multiple systemic conditions such as shock, tachycardia, tachypnea, hypotension and fever. The diagnosis of GPP was confirmed by the skin biopsy that reported morphological changes consistent with psoriasiform dermatitis. Treatment with vasopressors and biological agents was initiated, achieving remission of the clinical case.
Downloads
References
Romiti R, Hirayama S, Arnone M, Rena-ta Ferreira Magalhães. Generalized Pustular Psoriasis (von Zumbusch). Anais Brasileiros de Dermatologia. 2022 Jan 1; 97(1):63–74. https://doi.org/10.1016/j.abd.2021.05.011
Choon SE, Navarini AA, Pinter A. Clini-cal Course and Characteristics of Gener-alized Pustular Psoriasis. Am J Clin Der-matol. 2022; 23(S1):21–9Disponible en: http://dx.doi.org/10.1007/s40257-021-00654-z
Parisi R, Symmons D, Griffiths CEM, Ashcroft DM. Global Epidemiology of Psoriasis: A Systematic Review of Inci-dence and Prevalence. Journal of Investi-gative Dermatology. 2013; 133(2):377–85. https://doi.org/10.1038/jid.2012.339
Fujita H, Gooderham M, Romiti R. Diag-nosis of Generalized Pustular Psoriasis. Am J Clin Dermatol. 2022; 23(S1):31–8. https://doi.org/10.1007/s40257-021-00652-1
Rivera-Díaz R, Daudén E, Carrascosa JM, Cueva P de la, Puig L. Generalized Pustu-lar Psoriasis: A Review on Clinical Char-acteristics, Diagnosis, and Treatment. Der-matol Ther (Heidelb). 2023; 13(3):673–88. https://doi.org/10.1007/s13555-022-00881-0
Wang WM, Jin HZ. Biologics in the Treat-ment of Pustular Psoriasis. Expert Opin Drug Saf. 2020 Aug; 19(8):969-980.https://doi.org/10.1080/14740338.2020.1785427
oão Borges‐Costa, Silva R, Luz-ia Gonçalves, Filipe P, Luís Soares‐de‐Almeida, Gomes MM. Clinical and Lab-oratory Features in Acute Generalized Pustular Psoriasis. American Journal of Clin-ical Dermatology. 2011 Aug 1; 12(4):271–6. https://doi.org/10.2165/11586900-000000000-00000
News in Severe Clinical Adverse Drug Reac-tions: Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Gac Med Mex. 2015; 151(6).

Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora (Journal of Medical Students' of the University of Sonora)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.